Stock Price
2.97
Daily Change
-0.01 -0.17%
Monthly
-4.97%
Yearly
103.08%
Q1 Forecast
2.88

Galectin Therapeutics reported $186.9M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 391.49B 12.34B Feb/2026
Bristol-Myers Squibb USD 123.58B 13.77B Feb/2026
Galectin Therapeutics USD 103M 11M Dec/2023
Gilead Sciences USD 183.59B 31.31B Feb/2026
Immunic USD 68M 2M Dec/2023
Incyte USD 22.7B 3.31B Feb/2026
Merck USD 300.37B 39.11B Feb/2026